HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rheumatoid vasculitis: an update.

AbstractPURPOSE OF REVIEW:
Rheumatoid vasculitis is the most serious extra-articular complication of rheumatoid arthritis, with high morbidity and mortality noted in multiple prior reports. Recent studies have expanded our understanding of this entity in the era of modern immunosuppressive therapy. New clinical predictors and possible protective factors have also been identified.
RECENT FINDINGS:
This review provides an update on the epidemiology, clinical correlates, predictors, therapy and outcomes of rheumatoid vasculitis over the past decade. During this time, there has been increasing use of the treat-to-target management practices and incorporation of biologic response modifiers that have revolutionized rheumatoid arthritis treatment with better disease control and overall improved outcomes. The incidence of rheumatoid vasculitis has declined significantly in the past several decades, but morbidity and mortality continue to remain high, despite aggressive treatment with cyclophosphamide or biologic agents. Hydroxychloroquine and low-dose aspirin may have a protective role. There is ongoing debate about the role of newer biological therapies in prevention, treatment or even as a trigger for rheumatoid vasculitis.
SUMMARY:
Rheumatoid vasculitis remains a rare yet challenging extra-articular manifestation of rheumatoid arthritis with high morbidity and mortality, despite aggressive use of disease-modifying therapy.
AuthorsAshima Makol, Eric L Matteson, Kenneth J Warrington
JournalCurrent opinion in rheumatology (Curr Opin Rheumatol) Vol. 27 Issue 1 Pg. 63-70 (Jan 2015) ISSN: 1531-6963 [Electronic] United States
PMID25405822 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antirheumatic Agents
  • Immunologic Factors
Topics
  • Antirheumatic Agents (therapeutic use)
  • Diagnostic Imaging (methods)
  • Global Health
  • Humans
  • Immunologic Factors (therapeutic use)
  • Morbidity (trends)
  • Rheumatoid Vasculitis (diagnosis, drug therapy, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: